- Home
- CRMD vs GSBC Comparison
CRMD vs GSBC Comparison
Compare CRMD & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- GSBC
- Stock Information
- Founded
- CRMD 2006
- GSBC 1923
- Country
- CRMD United States
- GSBC United States
- Employees
- CRMD N/A
- GSBC N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- GSBC Major Banks
- Sector
- CRMD Health Care
- GSBC Finance
- Exchange
- CRMD Nasdaq
- GSBC Nasdaq
- Market Cap
- CRMD 645.0M
- GSBC N/A
- IPO Year
- CRMD 2010
- GSBC N/A
- Fundamental
- Price
- CRMD $6.06
- GSBC $55.70
- Analyst Decision
- CRMD Strong Buy
- GSBC Hold
- Analyst Count
- CRMD 7
- GSBC 1
- Target Price
- CRMD $15.14
- GSBC $64.00
- AVG Volume (30 Days)
- CRMD 2.0M
- GSBC 34.8K
- Earning Date
- CRMD 03-25-2025
- GSBC 04-16-2025
- Dividend Yield
- CRMD N/A
- GSBC 2.89%
- EPS Growth
- CRMD N/A
- GSBC N/A
- EPS
- CRMD N/A
- GSBC 5.26
- Revenue
- CRMD $43,472,170.00
- GSBC $214,292,000.00
- Revenue This Year
- CRMD $204.98
- GSBC N/A
- Revenue Next Year
- CRMD $22.54
- GSBC $2.25
- P/E Ratio
- CRMD N/A
- GSBC $10.53
- Revenue Growth
- CRMD N/A
- GSBC N/A
- 52 Week Low
- CRMD $3.61
- GSBC $49.74
- 52 Week High
- CRMD $13.85
- GSBC $68.02
- Technical
- Relative Strength Index (RSI)
- CRMD 22.86
- GSBC 39.30
- Support Level
- CRMD $6.92
- GSBC $56.85
- Resistance Level
- CRMD $11.32
- GSBC $58.60
- Average True Range (ATR)
- CRMD 0.65
- GSBC 1.17
- MACD
- CRMD -0.48
- GSBC 0.01
- Stochastic Oscillator
- CRMD 2.27
- GSBC 10.22
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.